Ursodeoxycholic acid use in lactating female patients is associated with clinically negligible concentrations of this bile acid in breast milk
Abstract In the literature on the safety of ursodeoxycholic acid (UDCA) during breastfeeding, insufficient data has been reported to date. Thus, the aim of our study was to analyze bile acid (BA) concentrations in breast milk in a cohort of patients, treated with UDCA, and with various cholestatic l...
Main Authors: | Patrik Šimják, Tomáš Petr, Barbora Kaslová, Tomáš Fejfar, Petr Hůlek, Antonín Pařízek, Libor Vítek |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-11-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-24253-y |
Similar Items
-
Author Correction: Ursodeoxycholic acid use in lactating female patients is associated with clinically negligible concentrations of this bile acid in breast milk
by: Patrik Šimják, et al.
Published: (2022-12-01) -
Overview of bile acids signaling and perspective on the signal of ursodeoxycholic acid, the most hydrophilic bile acid, in the heart
by: Hanafi, Noorul Izzati, et al.
Published: (2018) -
Dihydroartemisinin-Ursodeoxycholic Bile Acid Hybrids in the Fight against SARS-CoV‑2
by: Elena Marchesi, et al.
Published: (2023-11-01) -
Hepatic bile acids and bile acid-related gene expression in pregnant and lactating rats
by: Qiong N. Zhu, et al.
Published: (2013-08-01) -
Ursodeoxycholic acid and cancer prevention
by: A. R. Reyzis
Published: (2019-10-01)